PHK
VBIV

Point72 Hong Kong’s VBI Vaccines, Inc. New Common Stock (Canada) VBIV Stock Holding History

Point72 Hong Kong’s Portfolio VBIV Stock Details VBIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-473
Closed -$10K – 1845
2022
Q3 		$10K Sell
473
-732
-61% -$19.7K ﹤0.01% 1725
2022
Q2 		$29K Buy
+1,205
New +$41K ﹤0.01% 1481
2022
Q1 		– Sell
-614
Closed -$43K – 2491
2021
Q4 		$43K Buy
+614
New +$51.7K ﹤0.01% 1381
2021
Q2 		– Sell
-135
Closed -$13K – 2465
2021
Q1 		$13K Buy
+135
New +$13.7K ﹤0.01% 1559
2020
Q3 		– Sell
-328
Closed -$30K – 1610
2020
Q2 		$30K Buy
+328
New +$18.1K ﹤0.01% 828

Other funds holding VBIV

PA
Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GAI
General American Investors New York $1.51B AUM 37.94% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return